The team behind the research believe that it displays a need for the reallocation of resource towards more effective treatments for patients.
Parkinson’s disease is a degenerative disorder of the central nervous system, affecting approximately seven million people across the globe and 4% of those aged over 80.
Current national guidelines state that patients should have access to both types of therapy, although there is a geographical inconsistency of care available in the UK.
Professor Carl Clarke, from the University of Birmingham said, “This shows that there is an urgent requirement to review current guidelines for patients with Parkinson’s disease. The resource that is committed towards these therapies, that do not appear to be effective, could be better used in patients with more severe problems with their Parkinson’s disease.”
“That said, it is likely that increasing physical activity is beneficial for patients with earlier Parkinson’s, whether that be through dance classes or by using some of the emerging, interactive technologies that are being tested. The big challenge is to embed that behaviour long term, and to encourage more exercise over a long period of time.”
762 patients with mild to moderate Parkinson’s disease were recruited from 37 centres across the UK, making it the largest clinical trial of rehabilitation in Parkinson’s disease, and follow ups were measured for 15 months. This study was a randomised controlled trial, which is one of the best ways for determining whether a treatment actually has the desired effect.
Professor Clarke, who also holds a position at Sandwell and West Birmingham Hospitals NHS Trust, added, “It is difficult to advocate the removal of something from guidelines when it was assumed to be beneficial. Though these therapies can provide marginal improvements to motor function, perhaps an extra centimetre in your stride, they don’t lead to benefits in the quality of day to day life.”
The team, who have previously published large scale trials on the efficacy of medical (PD MED trial) and surgical (PD SURG trial) therapies for Parkinson’s disease, are now looking to investigate the speech and language therapies available (PD COMM trial).
Notes to editors
For interview requests, a copy of the full paper or for more information, please contact Luke Harrison, Media Relations Manager, University of Birmingham on +44 (0)121 414 5134.
For out of hours media enquiries, please call: +44 (0) 7789 921 165
1. The National Institute for Health Research Health Technology Assessment (NIHR HTA) Programme funds research about the effectiveness, costs, and broader impact of health technologies for those who use, manage and provide care in the NHS. It is the largest NIHR programme and publishes the results of its research in the Health Technology Assessment journal, with over 700 issues published to date. The journal’s 2014 Impact Factor (5.027) ranked it two out of 85 publications in the Health Care Sciences and Services category. All issues are available for download, free of charge, from the website. The HTA Programme is funded by the NIHR, with contributions from the CSO in Scotland, NISCHR in Wales, and the HSC R&D Division, Public Health Agency in Northern Ireland.www.nets.nihr.ac.uk/programmes/hta
2. The National Institute for Health Research (NIHR) is funded by the Department of Health to improve the health and wealth of the nation through research. Since its establishment in April 2006, the NIHR has transformed research in the NHS. It has increased the volume of applied health research for the benefit of patients and the public, driven faster translation of basic science discoveries into tangible benefits for patients and the economy, and developed and supported the people who conduct and contribute to applied health research. The NIHR plays a key role in the Government’s strategy for economic growth, attracting investment by the life-sciences industries through its world-class infrastructure for health research. Together, the NIHR people, programmes, centres of excellence and systems represent the most integrated health research system in the world. For further information, visit the NIHR website (www.nihr.ac.uk).
This article presents independent research funded by the National Institute for Health Research (NIHR). The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health.